Trial

NCT05406219

A Study to Learn How the Study Treatment BAY2395840 Moves Into, Through and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Moderate Reduced Kidney Function and in Healthy Male and Female Participants With Normal Kidney Function
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Bayer
Collaborators
Condition
Diabetic Neuropathic Pain
Intervention
BAY2395840
Why stopped
Discontinuation of program.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-04-19